Primary Site >> Colorectal Cancer

Gene >> HMMR

  • 1995
  • 1999
  • 2001
  • 2002
  • 2006
  • 2007
  • 2008
  • 2010
  • 2011
  • 2015
  • 2017
Ref: The modulation of granulomatous tissue and tumour angiogenesis by diclofenac in combination with hyaluronan (HYAL EX-0001).
PMID: 8867646
Ref: Receptor for hyaluronan-mediated motility and CD44 expressions in colon cancer assessed by quantitative analysis using real-time reverse transcriptase-polymerase chain reaction.
PMID: 10551329
Ref: Evolution of instability at coding and non-coding repeat sequences in human MSI-H colorectal cancers.
PMID: 11181575
Ref: Characterisation of tumour-associated antigens in colon cancer.
PMID: 12384809
Ref: Overexpression of the receptor for hyaluronic acid mediated motility is an independent adverse prognostic factor in colorectal cancer.
PMID: 16763611
Ref: Selecting immunohistochemical cut-off scores for novel biomarkers of progression and survival in colorectal cancer.
PMID: 17182662
Ref: Node-negative colorectal cancer at high risk of distant metastasis identified by combined analysis of lymph node status, vascular invasion, and Raf-1 kinase inhibitor protein expression.
PMID: 18172264
Ref: Role of RHAMM within the hierarchy of well-established prognostic factors in colorectal cancer.
PMID: 18436576
Ref: RHAMM, p21 combined phenotype identifies microsatellite instability-high colorectal cancers with a highly adverse prognosis.
PMID: 18559599
Ref: Two-marker protein profile predicts poor prognosis in patients with early rectal cancer.
PMID: 18985041
Ref: Systematic assessment of protein phenotypes characterizing high-grade tumour budding in mismatch repair-proficient colorectal cancer.
PMID: 20716165
Ref: Loss of E-cadherin independently predicts the lymph node status in colorectal cancer.
PMID: 21233674
Ref: VEGFA gene locus (6p12) amplification identifies a small but highly aggressive subgroup of colorectal cancer [corrected] patients.
PMID: 21743435
Ref: Expression of the hyaluronan-mediated motility receptor RHAMM in tumor budding cells identifies aggressive colorectal cancers.
PMID: 26351067
Ref: The hyaluronan-mediated motility receptor RHAMM promotes growth, invasiveness and dissemination of colorectal cancer.
PMID: 29050306